Clinical Trial Detail

NCT ID NCT01587040
Title Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors Sanofi
Indications

Advanced Solid Tumor

Therapies

XL147

SAR245409

Age Groups: adult

No variant requirements are available.